Application no. and date | 08832690.5 (espacenet) (Federated) (European Patent Register), 20080917 | Patent/reg. no. and date | DK/EP 2195026, 20131225 | Publication date | 20100616 | Priority no. and date | US 973024 P, 20070917 | EP pub. no. and date |
EP 2195026 20100616 | Effective date | | Applicant/owner | Amgen, Inc, Patent Operations, M/S 28-2-C One Amgen Center Drive
Thousand Oaks, California 91320-1799, US | Applicant ref. no. | P81400370DK00E | Inventor | PADHI, Ian, Desmond, 1079 Via Impresso
Newbury Park CA 91320, US, JANG, Graham, Richard, 1223 20th Street 202
Santa Monica, CA 90404, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 19/08 (2006.01) | Title | Anti-sclerostin-antistoffer | Int. application no. | US2008076679 | Int. publication no. | WO2009039175 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|